- call +1-201-465-4211
- email sales@mrinsights.biz
African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense.
Scope of the Report:
This report studies the African Trypanosomiasis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the African Trypanosomiasis market by product type and applications/end industries.
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.
The symptoms associated with African Trypanosoniasis vary from one stage to another. There are two stages which are as follows. First Stage (Hemolymphatic stage): The first stage is known as hemolymphatic stage due to the blood and lymphatic systems associated with this stage. During this stage, the skin infected by the tsetse fly form a trypanosomal chancre and the lymph nodes of the immune system become infected and enlarged. The various symptoms of the hemolymphatic stage are intermittent fever, headaches, skin lesions, facial edema, tachycardia and weight loss. Second stage (Neurologic or encephalitic stage): During the second stage, the brain becomes affected with few troubles in concentrating. The various symptoms of the neurologic stage are muscle weakness, behavioral changes such as irritability and mood swings, paralysis of a limb, speech disorders and sensory disorders.
The global African Trypanosomiasis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of African Trypanosomiasis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense
Market Segment by Applications, can be divided into
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 African Trypanosomiasis Market Overview
1.1 Product Overview and Scope of African Trypanosomiasis
1.2 Classification of African Trypanosomiasis by Types
1.2.1 Global African Trypanosomiasis Revenue Comparison by Types (2017-2023)
1.2.2 Global African Trypanosomiasis Revenue Market Share by Types in 2017
1.2.3 Trypanosoma Brucei Rhodesiense
1.2.4 Trypanosomiasis Brucei Gambiense
1.3 Global African Trypanosomiasis Market by Application
1.3.1 Global African Trypanosomiasis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Blood Samples
1.3.3 Bone Marrow
1.3.4 Lymph Node Fluid
1.3.5 Cerebrospinal Fluid or Lymph Node Aspirate
1.4 Global African Trypanosomiasis Market by Regions
1.4.1 Global African Trypanosomiasis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) African Trypanosomiasis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) African Trypanosomiasis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) African Trypanosomiasis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) African Trypanosomiasis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) African Trypanosomiasis Status and Prospect (2013-2023)
1.5 Global Market Size of African Trypanosomiasis (2013-2023)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 African Trypanosomiasis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi African Trypanosomiasis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Genzyme Corporation
2.2.1 Business Overview
2.2.2 African Trypanosomiasis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Genzyme Corporation African Trypanosomiasis Revenue, Gross Margin and Market Share (2016-2017)
2.3 aRigen Pharmaceuticals
2.3.1 Business Overview
2.3.2 African Trypanosomiasis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 aRigen Pharmaceuticals African Trypanosomiasis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Immtech Pharmaceuticals
2.4.1 Business Overview
2.4.2 African Trypanosomiasis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Immtech Pharmaceuticals African Trypanosomiasis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Anacor Pharmaceuticals
2.5.1 Business Overview
2.5.2 African Trypanosomiasis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Anacor Pharmaceuticals African Trypanosomiasis Revenue, Gross Margin and Market Share (2016-2017)
3 Global African Trypanosomiasis Market Competition, by Players
3.1 Global African Trypanosomiasis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 African Trypanosomiasis Players Market Share
3.2.2 Top 10 African Trypanosomiasis Players Market Share
3.3 Market Competition Trend
4 Global African Trypanosomiasis Market Size by Regions
4.1 Global African Trypanosomiasis Revenue and Market Share by Regions
4.2 North America African Trypanosomiasis Revenue and Growth Rate (2013-2018)
4.3 Europe African Trypanosomiasis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific African Trypanosomiasis Revenue and Growth Rate (2013-2018)
4.5 South America African Trypanosomiasis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa African Trypanosomiasis Revenue and Growth Rate (2013-2018)
5 North America African Trypanosomiasis Revenue by Countries
5.1 North America African Trypanosomiasis Revenue by Countries (2013-2018)
5.2 USA African Trypanosomiasis Revenue and Growth Rate (2013-2018)
5.3 Canada African Trypanosomiasis Revenue and Growth Rate (2013-2018)
5.4 Mexico African Trypanosomiasis Revenue and Growth Rate (2013-2018)
6 Europe African Trypanosomiasis Revenue by Countries
6.1 Europe African Trypanosomiasis Revenue by Countries (2013-2018)
6.2 Germany African Trypanosomiasis Revenue and Growth Rate (2013-2018)
6.3 UK African Trypanosomiasis Revenue and Growth Rate (2013-2018)
6.4 France African Trypanosomiasis Revenue and Growth Rate (2013-2018)
6.5 Russia African Trypanosomiasis Revenue and Growth Rate (2013-2018)
6.6 Italy African Trypanosomiasis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific African Trypanosomiasis Revenue by Countries
7.1 Asia-Pacific African Trypanosomiasis Revenue by Countries (2013-2018)
7.2 China African Trypanosomiasis Revenue and Growth Rate (2013-2018)
7.3 Japan African Trypanosomiasis Revenue and Growth Rate (2013-2018)
7.4 Korea African Trypanosomiasis Revenue and Growth Rate (2013-2018)
7.5 India African Trypanosomiasis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia African Trypanosomiasis Revenue and Growth Rate (2013-2018)
8 South America African Trypanosomiasis Revenue by Countries
8.1 South America African Trypanosomiasis Revenue by Countries (2013-2018)
8.2 Brazil African Trypanosomiasis Revenue and Growth Rate (2013-2018)
8.3 Argentina African Trypanosomiasis Revenue and Growth Rate (2013-2018)
8.4 Colombia African Trypanosomiasis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue African Trypanosomiasis by Countries
9.1 Middle East and Africa African Trypanosomiasis Revenue by Countries (2013-2018)
9.2 Saudi Arabia African Trypanosomiasis Revenue and Growth Rate (2013-2018)
9.3 UAE African Trypanosomiasis Revenue and Growth Rate (2013-2018)
9.4 Egypt African Trypanosomiasis Revenue and Growth Rate (2013-2018)
9.5 Nigeria African Trypanosomiasis Revenue and Growth Rate (2013-2018)
9.6 South Africa African Trypanosomiasis Revenue and Growth Rate (2013-2018)
10 Global African Trypanosomiasis Market Segment by Type
10.1 Global African Trypanosomiasis Revenue and Market Share by Type (2013-2018)
10.2 Global African Trypanosomiasis Market Forecast by Type (2018-2023)
10.3 Trypanosoma Brucei Rhodesiense Revenue Growth Rate (2013-2023)
10.4 Trypanosomiasis Brucei Gambiense Revenue Growth Rate (2013-2023)
11 Global African Trypanosomiasis Market Segment by Application
11.1 Global African Trypanosomiasis Revenue Market Share by Application (2013-2018)
11.2 African Trypanosomiasis Market Forecast by Application (2018-2023)
11.3 Blood Samples Revenue Growth (2013-2018)
11.4 Bone Marrow Revenue Growth (2013-2018)
11.5 Lymph Node Fluid Revenue Growth (2013-2018)
11.6 Cerebrospinal Fluid or Lymph Node Aspirate Revenue Growth (2013-2018)
12 Global African Trypanosomiasis Market Size Forecast (2018-2023)
12.1 Global African Trypanosomiasis Market Size Forecast (2018-2023)
12.2 Global African Trypanosomiasis Market Forecast by Regions (2018-2023)
12.3 North America African Trypanosomiasis Revenue Market Forecast (2018-2023)
12.4 Europe African Trypanosomiasis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific African Trypanosomiasis Revenue Market Forecast (2018-2023)
12.6 South America African Trypanosomiasis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa African Trypanosomiasis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure African Trypanosomiasis Picture
Table Product Specifications of African Trypanosomiasis
Table Global African Trypanosomiasis and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
